MetaCap

MoonLake Immunotherapeutics Class A Company Profile

NASDAQ: MLTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.07+0.04 (+0.36%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MoonLake Immunotherapeutics at a glance

MoonLake Immunotherapeutics Class A (NASDAQ: MLTX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Zug. MoonLake Immunotherapeutics is led by Dr. Jorge Santos da Silva Ph.D. and employs about 130 people. The company's shares have traded publicly since 2020.

At a market capitalization of $938.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001821586, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does MoonLake Immunotherapeutics do?

MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

Business description based on the company's public filings.

Company information

Legal name
MoonLake Immunotherapeutics Class A
Ticker
NASDAQ: MLTX
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Jorge Santos da Silva Ph.D.
Employees
130
Headquarters
Dorfstrasse 29, Zug, United States
Phone
41 415108022
IPO year
2020
Market cap
$938.73M
SEC CIK
0001821586
Latest annual report
10-K · Feb 25, 2026

Companies similar to MoonLake Immunotherapeutics

MLTX peer companies
CompanyPrice% ChgMarket capCompare
SVRASavara Inc.4.26-18.23%$939.86Mvs MLTX
CYRXCryoPort Inc.19.05-2.56%$964.87Mvs MLTX
SPTXSeaport Therapeutics Inc.18.05-1.47%$966.23Mvs MLTX
AKTSAktis Oncology Inc.16.15-1.52%$901.14Mvs MLTX
OMEROmeros Corporation13.21-5.71%$983.66Mvs MLTX
LTGOLatigo Biotherapeutics Inc.13.00-1.81%$861.89Mvs MLTX
ANROAlto Neuroscience Inc.25.37-4.30%$1.02Bvs MLTX
MTRIMentari Therapeutics Inc.14.70-3.57%$856.94Mvs MLTX

Related